Holen Sie sich die Stockscreener-App
0.419
6.31%
-0.0282
Handel nachbörslich:
.41
-0.009
-2.15%
Finanzdaten der Leap Therapeutics Inc-Aktie (LPTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
6.06%
16.88
|
15.92 | 16.12 | 17.86 | 21.25 |
| Operating Income/Loss |
6.06%
-16.88
|
-15.92 | -16.12 | -17.86 | -21.25 |
| Income/Loss From Continuing Operations Before Tax |
7.83%
-16.64
|
-15.44 | -15.55 | -17.47 | -20.13 |
| Income/Loss From Continuing Operations After Tax |
7.83%
-16.64
|
-15.44 | -15.43 | -18.18 | -20.13 |
|
Net Income/Loss
|
7.83%
-16.64
|
-15.44 | -15.43 | -18.18 | -20.13 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | 0.234 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.43%
41.44
|
41.27 | 1.2428 | 41.21 | 39.12 |
| Diluted Average Shares |
0.43%
41.44
|
41.27 | 1.2428 | 41.21 | 39.12 |
| Basic Earnings Per Share |
8.11%
-0.40
|
-0.37 | -0.37 | -0.44 | -0.52 |
| Diluted Earnings Per Share |
8.11%
-0.40
|
-0.37 | -0.37 | -0.44 | -0.52 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | 0.234 |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):